Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis

CONTEXT: Prostate cancer (PCa) is the second most common type of cancer in men. Individualized risk stratification is crucial to adjust decision-making. A variety of molecular biomarkers have been developed in order to identify patients at risk of clinically significant PCa (csPCa) defined by the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: del Pino-Sedeño, Tasmania, Infante-Ventura, Diego, de Armas Castellano, Aythami, de Pablos-Rodríguez, Pedro, Rueda-Domínguez, Antonio, Serrano-Aguilar, Pedro, Trujillo-Martín, María M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review – Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664479/
https://www.ncbi.nlm.nih.gov/pubmed/36388432
http://dx.doi.org/10.1016/j.euros.2022.10.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664479/
https://www.ncbi.nlm.nih.gov/pubmed/36388432
http://dx.doi.org/10.1016/j.euros.2022.10.017

Ejemplares similares